GLOBAL INTRAGASTRIC BALLOONS MARKET FORECAST 2018-2026
KEY FINDINGS
The global market for intragastric balloon was valued at $ 148.0 million in the year 2017 and is evolving to $303.3 million by 2026. The growth of the market is expected at 8.30% of CAGR throughout the forecasting years 2018 to 2026. The base year considered for the market study is 2017. Unhealthy lifestyle and less stays at the hospital and fast recovery after intragastric ballooning are few of the driving factors up surging the intragastric balloon market across the globe.
MARKET INSIGHTS
The numerous obese population and less expenditure of intragastric ballooning has proliferated the demand for intragastric balloon across the world. It is estimated that almost 2 million adults and children around the world are obese and go through many health problems due to their overweight. This is majorly attributed to urbanization, poor diets and inactiveness among people. The intragastric balloon market segmentation consists of filling materials, end-use, and products. Lack of reimbursement and stringent approval on products are key reasons restraining the growth of the intragastric balloon market.
REGIONAL INSIGHTS
The global market for intragastric balloon comprises of key regions such as North America, EMEA, and the Asia Pacific. The EMEA region is anticipated to lead the intragastric balloon market during the forecast period. Change in the consumption of food patterns is the major reason responsible for the overweight and obese population in Europe, which is increasing the market in Europe. On the other hand, North America region is expected to evolve rapidly with the highest growth rate over the estimated years.
COMPETITIVE INSIGHTS
The established players in the global intragastric balloon market are Apollo Endosurgery, Inc., Allurion Technologies Inc., Reshape Medical Inc., Hélioscopie Sa, Spatz Fgia Inc., Silimed, Inc., Obalon Therapeutics Inc., Medsil, Life Partners Europe, Tulip Medical Ltd., Baronova, Inc., and Endalis.
The global market for intragastric balloon was valued at $ 148.0 million in the year 2017 and is evolving to $303.3 million by 2026. The growth of the market is expected at 8.30% of CAGR throughout the forecasting years 2018 to 2026. The base year considered for the market study is 2017. Unhealthy lifestyle and less stays at the hospital and fast recovery after intragastric ballooning are few of the driving factors up surging the intragastric balloon market across the globe.
MARKET INSIGHTS
The numerous obese population and less expenditure of intragastric ballooning has proliferated the demand for intragastric balloon across the world. It is estimated that almost 2 million adults and children around the world are obese and go through many health problems due to their overweight. This is majorly attributed to urbanization, poor diets and inactiveness among people. The intragastric balloon market segmentation consists of filling materials, end-use, and products. Lack of reimbursement and stringent approval on products are key reasons restraining the growth of the intragastric balloon market.
REGIONAL INSIGHTS
The global market for intragastric balloon comprises of key regions such as North America, EMEA, and the Asia Pacific. The EMEA region is anticipated to lead the intragastric balloon market during the forecast period. Change in the consumption of food patterns is the major reason responsible for the overweight and obese population in Europe, which is increasing the market in Europe. On the other hand, North America region is expected to evolve rapidly with the highest growth rate over the estimated years.
COMPETITIVE INSIGHTS
The established players in the global intragastric balloon market are Apollo Endosurgery, Inc., Allurion Technologies Inc., Reshape Medical Inc., Hélioscopie Sa, Spatz Fgia Inc., Silimed, Inc., Obalon Therapeutics Inc., Medsil, Life Partners Europe, Tulip Medical Ltd., Baronova, Inc., and Endalis.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. HIGH RATE OF OBESITY
3.2.2. CHANGING STRUCTURE OF THE HEALTHCARE INDUSTRY
3.2.3. EMEA DOMINATED THE MARKET
4. MARKET OVERVIEW
4.1. OBESITY
4.2. BMI RANGES
4.3. MORBID OBESITY
4.4. LOSING WEIGHT
4.5. HISTORY OF INTRAGASTRIC BALLOONS
4.6. RE-ENTRY OF INTRAGASTRIC BALLOONS
4.7. ADVANTAGES OF INTRAGASTRIC BALLOONS
4.8. COMPLICATIONS ASSOCIATED WITH INTRAGASTRIC BALLOONS
4.9. WHO IS NOT SUITABLE FOR PLACEMENT OF INTRAGASTRIC BALLOON
5. MARKET DETERMINANTS
5.1. MARKET DRIVERS
5.1.1. HUGE OBESE POPULATION
5.1.2. UNHEALTHY LIFESTYLE
5.1.3. LOW PRICE OF INTRAGASTRIC BALLOONING
5.1.4. SHORT HOSPITAL STAY AND SHORT RECOVERY TIME POST-INTRAGASTRIC BALLOONING
5.2. MARKET RESTRAINTS
5.2.1. STRINGENT PRODUCT APPROVAL
5.2.2. SHORT-TERM EFFECTS OF INTRAGASTRIC BALLOONING FOR WEIGHT LOSS
5.2.3. ADVERSE EVENTS OF INTRAGASTRIC BALLOONS
5.2.4. LACK OF REIMBURSEMENT FOR INTRAGASTRIC BALLOONING
5.3. MARKET OPPORTUNITIES
5.3.1. HUGE OBESE POPULATION
5.3.2. MANDATE TO CURTAIL HEALTHCARE COSTS
5.3.3. PRODUCT APPROVALS IN THE US
6. MARKET SEGMENTATION
6.1. MARKET BY PRODUCT 2018-2026
6.1.1. SINGLE BALLOON
6.1.2. DUAL BALLOON
6.1.3. TRIPLE BALLOON
6.2. MARKET BY FILLING MATERIAL 2018-2026
6.2.1. SALINE-FILLED
6.2.2. GAS-FILLED
6.3. MARKET BY END-USE 2018-2026
6.3.1. HOSPITALS
6.3.2. AMBULATORY SURGICAL CENTERS
6.3.3. CLINICS
7. KEY ANALYTICS
7.1. PORTERS FIVE FORCES ANALYSIS
7.1.1. THREAT OF NEW ENTRANTS
7.1.2. THREAT OF SUBSTITUTES
7.1.3. BARGAINING POWER OF BUYERS
7.1.4. BARGAINING POWER OF SUPPLIERS
7.1.5. THREAT OF RIVALRY
7.2. VALUE CHAIN ANALYSIS
7.2.1. RESEARCH AND DEVELOPMENT
7.2.2. MANUFACTURING
7.2.3. ASSEMBLY
7.2.4. DISTRIBUTION AND SALES & MARKETING
7.2.5. POST SALES SERVICES
7.3. SUPPLY CHAIN ANALYSIS
7.3.1. STAKEHOLDERS IN SUPPLY CHAIN
7.3.1.1. KEY PLAYERS
7.3.1.2. SMALL & MEDIUM ENTERPRISES (SMES)
7.3.1.3. END-USERS
7.3.2. KEY INFLUENCERS
7.4. KEY MARKET TRENDS
7.4.1. PRODUCT APPROVALS
7.4.2. FOCUS OF HOSPITALS ON PATIENT SANITY
7.4.3. TECHNOLOGICAL ADVANCEMENTS
7.5. REGULATIONS IN EUROPE
7.6. STUDIES ON INTRAGASTRIC BALLOONING
8. GEOGRAPHICAL ANALYSIS
8.1. AMERICAS
8.1.1. UNITED STATES
8.1.2. CANADA
8.1.3. BRAZIL
8.1.4. REST OF AMERICAS
8.2. EUROPE, MIDDLE EAST AND AFRICA (EMEA)
8.2.1. GERMANY
8.2.2. UNITED KINGDOM
8.2.3. FRANCE
8.2.4. ITALY
8.2.5. SPAIN
8.2.6. REST OF EUROPE (ROE)
8.2.7. MIDDLE EAST
8.2.8. AFRICA
8.3. ASIA-PACIFIC
8.3.1. JAPAN
8.3.2. CHINA
8.3.3. INDIA
8.3.4. REST OF ASIA-PACIFIC (ROAPAC)
8.3.4.1. AUSTRALIA
8.3.4.2. NEW ZEALAND
8.3.4.3. KOREA
9. COMPANY PROFILE
9.1. MARKET SHARE ANALYSIS
9.2. APOLLO ENDOSURGERY, INC.
9.3. ALLURION TECHNOLOGIES INC.
9.4. RESHAPE MEDICAL INC.
9.5. HÉLIOSCOPIE SA
9.6. SPATZ FGIA INC.
9.7. SILIMED, INC.
9.8. OBALON THERAPEUTICS INC.
9.9. MEDSIL
9.10. LIFE PARTNERS EUROPE
9.11. TULIP MEDICAL LTD.
9.12. BARONOVA, INC.
9.13. ENDALIS
TABLE LIST
TABLE 1 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 2 AVERAGE COST OF INTRAGASTRIC BALLOON TREATMENT ACROSS COUNTRIES
TABLE 3 NUMBER OF INTRAGASTRIC BALLOONS SURGERY IN THE MAJOR COUNTRIES IN 2016
TABLE 4 AVERAGE COST OF INTRAGASTRIC BALLOON TREATMENT ACROSS COUNTRIES
TABLE 5 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY PRODUCT 2018-2026 ($ MILLION)
TABLE 6 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY FILLING MATERIAL 2018-2026 ($ MILLION)
TABLE 7 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY END USE 2018-2026 ($ MILLION)
TABLE 8 REGULATIONS FOR MEDICAL DEVICES IN EUROPE
TABLE 9 GLOBAL INTRAGASTRIC BALLOONS MARKET BY GEOGRAPHY 2018-2026 ($MILLION)
TABLE 10 MOST OBESE COUNTRIES IN THE WORLD
TABLE 11 AMERICAS INTRAGASTRIC BALLOONS MARKET BY COUNTRY 2018-2026($MILLION)
TABLE 12 ESTIMATE OF BARIATRIC SURGERY NUMBERS IN THE US (2011-2015)
TABLE 13 EUROPE OBESITY LEAGUE
TABLE 14 EMEA INTRAGASTRIC BALLOONS MARKET BY COUNTRY 2018-2026($MILLION)
TABLE 15 ASIA-PACIFIC INTRAGASTRIC BALLOONS MARKET BY COUNTRY 2018-2026 ($MILLION)
TABLE 16 COST OF WEIGHT-LOSS SURGERIES IN THE US V/S INDIA IN $
TABLE 17 OBESE/OVERWEIGHT STATISTICS IN AUSTRALIA (IN MILLIONS)
TABLE 18 COST OF INTRAGASTRIC BALLOONING IN AUSTRALIA, BY PROGRAM
TABLE 19 COSTS OF SURGERIES IN AUSTRALIA
TABLE 20 NOTEWORTHY INTRAGASTRIC BALLOONS PRODUCTS IN THE MARKET
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. HIGH RATE OF OBESITY
3.2.2. CHANGING STRUCTURE OF THE HEALTHCARE INDUSTRY
3.2.3. EMEA DOMINATED THE MARKET
4. MARKET OVERVIEW
4.1. OBESITY
4.2. BMI RANGES
4.3. MORBID OBESITY
4.4. LOSING WEIGHT
4.5. HISTORY OF INTRAGASTRIC BALLOONS
4.6. RE-ENTRY OF INTRAGASTRIC BALLOONS
4.7. ADVANTAGES OF INTRAGASTRIC BALLOONS
4.8. COMPLICATIONS ASSOCIATED WITH INTRAGASTRIC BALLOONS
4.9. WHO IS NOT SUITABLE FOR PLACEMENT OF INTRAGASTRIC BALLOON
5. MARKET DETERMINANTS
5.1. MARKET DRIVERS
5.1.1. HUGE OBESE POPULATION
5.1.2. UNHEALTHY LIFESTYLE
5.1.3. LOW PRICE OF INTRAGASTRIC BALLOONING
5.1.4. SHORT HOSPITAL STAY AND SHORT RECOVERY TIME POST-INTRAGASTRIC BALLOONING
5.2. MARKET RESTRAINTS
5.2.1. STRINGENT PRODUCT APPROVAL
5.2.2. SHORT-TERM EFFECTS OF INTRAGASTRIC BALLOONING FOR WEIGHT LOSS
5.2.3. ADVERSE EVENTS OF INTRAGASTRIC BALLOONS
5.2.4. LACK OF REIMBURSEMENT FOR INTRAGASTRIC BALLOONING
5.3. MARKET OPPORTUNITIES
5.3.1. HUGE OBESE POPULATION
5.3.2. MANDATE TO CURTAIL HEALTHCARE COSTS
5.3.3. PRODUCT APPROVALS IN THE US
6. MARKET SEGMENTATION
6.1. MARKET BY PRODUCT 2018-2026
6.1.1. SINGLE BALLOON
6.1.2. DUAL BALLOON
6.1.3. TRIPLE BALLOON
6.2. MARKET BY FILLING MATERIAL 2018-2026
6.2.1. SALINE-FILLED
6.2.2. GAS-FILLED
6.3. MARKET BY END-USE 2018-2026
6.3.1. HOSPITALS
6.3.2. AMBULATORY SURGICAL CENTERS
6.3.3. CLINICS
7. KEY ANALYTICS
7.1. PORTERS FIVE FORCES ANALYSIS
7.1.1. THREAT OF NEW ENTRANTS
7.1.2. THREAT OF SUBSTITUTES
7.1.3. BARGAINING POWER OF BUYERS
7.1.4. BARGAINING POWER OF SUPPLIERS
7.1.5. THREAT OF RIVALRY
7.2. VALUE CHAIN ANALYSIS
7.2.1. RESEARCH AND DEVELOPMENT
7.2.2. MANUFACTURING
7.2.3. ASSEMBLY
7.2.4. DISTRIBUTION AND SALES & MARKETING
7.2.5. POST SALES SERVICES
7.3. SUPPLY CHAIN ANALYSIS
7.3.1. STAKEHOLDERS IN SUPPLY CHAIN
7.3.1.1. KEY PLAYERS
7.3.1.2. SMALL & MEDIUM ENTERPRISES (SMES)
7.3.1.3. END-USERS
7.3.2. KEY INFLUENCERS
7.4. KEY MARKET TRENDS
7.4.1. PRODUCT APPROVALS
7.4.2. FOCUS OF HOSPITALS ON PATIENT SANITY
7.4.3. TECHNOLOGICAL ADVANCEMENTS
7.5. REGULATIONS IN EUROPE
7.6. STUDIES ON INTRAGASTRIC BALLOONING
8. GEOGRAPHICAL ANALYSIS
8.1. AMERICAS
8.1.1. UNITED STATES
8.1.2. CANADA
8.1.3. BRAZIL
8.1.4. REST OF AMERICAS
8.2. EUROPE, MIDDLE EAST AND AFRICA (EMEA)
8.2.1. GERMANY
8.2.2. UNITED KINGDOM
8.2.3. FRANCE
8.2.4. ITALY
8.2.5. SPAIN
8.2.6. REST OF EUROPE (ROE)
8.2.7. MIDDLE EAST
8.2.8. AFRICA
8.3. ASIA-PACIFIC
8.3.1. JAPAN
8.3.2. CHINA
8.3.3. INDIA
8.3.4. REST OF ASIA-PACIFIC (ROAPAC)
8.3.4.1. AUSTRALIA
8.3.4.2. NEW ZEALAND
8.3.4.3. KOREA
9. COMPANY PROFILE
9.1. MARKET SHARE ANALYSIS
9.2. APOLLO ENDOSURGERY, INC.
9.3. ALLURION TECHNOLOGIES INC.
9.4. RESHAPE MEDICAL INC.
9.5. HÉLIOSCOPIE SA
9.6. SPATZ FGIA INC.
9.7. SILIMED, INC.
9.8. OBALON THERAPEUTICS INC.
9.9. MEDSIL
9.10. LIFE PARTNERS EUROPE
9.11. TULIP MEDICAL LTD.
9.12. BARONOVA, INC.
9.13. ENDALIS
TABLE LIST
TABLE 1 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 2 AVERAGE COST OF INTRAGASTRIC BALLOON TREATMENT ACROSS COUNTRIES
TABLE 3 NUMBER OF INTRAGASTRIC BALLOONS SURGERY IN THE MAJOR COUNTRIES IN 2016
TABLE 4 AVERAGE COST OF INTRAGASTRIC BALLOON TREATMENT ACROSS COUNTRIES
TABLE 5 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY PRODUCT 2018-2026 ($ MILLION)
TABLE 6 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY FILLING MATERIAL 2018-2026 ($ MILLION)
TABLE 7 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY END USE 2018-2026 ($ MILLION)
TABLE 8 REGULATIONS FOR MEDICAL DEVICES IN EUROPE
TABLE 9 GLOBAL INTRAGASTRIC BALLOONS MARKET BY GEOGRAPHY 2018-2026 ($MILLION)
TABLE 10 MOST OBESE COUNTRIES IN THE WORLD
TABLE 11 AMERICAS INTRAGASTRIC BALLOONS MARKET BY COUNTRY 2018-2026($MILLION)
TABLE 12 ESTIMATE OF BARIATRIC SURGERY NUMBERS IN THE US (2011-2015)
TABLE 13 EUROPE OBESITY LEAGUE
TABLE 14 EMEA INTRAGASTRIC BALLOONS MARKET BY COUNTRY 2018-2026($MILLION)
TABLE 15 ASIA-PACIFIC INTRAGASTRIC BALLOONS MARKET BY COUNTRY 2018-2026 ($MILLION)
TABLE 16 COST OF WEIGHT-LOSS SURGERIES IN THE US V/S INDIA IN $
TABLE 17 OBESE/OVERWEIGHT STATISTICS IN AUSTRALIA (IN MILLIONS)
TABLE 18 COST OF INTRAGASTRIC BALLOONING IN AUSTRALIA, BY PROGRAM
TABLE 19 COSTS OF SURGERIES IN AUSTRALIA
TABLE 20 NOTEWORTHY INTRAGASTRIC BALLOONS PRODUCTS IN THE MARKET
FIGURES LIST
FIGURE 1 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)
FIGURE 2 OBESITY WORLDWIDE 2016 (IN MILLIONS)
FIGURE 3 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY PRODUCT 2018-2026 ($ MILLION)
FIGURE 4 GLOBAL INTRAGASTRIC BALLOONS MARKET IN SINGLE BALLOON 2018-2026 ($ MILLION)
FIGURE 5 GLOBAL INTRAGASTRIC BALLOONS MARKET IN DUAL BALLOON 2018-2026 ($ MILLION)
FIGURE 6 GLOBAL INTRAGASTRIC BALLOONS MARKET IN TRIPLE BALLOON 2018-2026 ($ MILLION)
FIGURE 7 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY FILLING MATERIAL 2018-2026 ($ MILLION)
FIGURE 8 GLOBAL INTRAGASTRIC BALLOONS MARKET IN SALINE-FILLED 2018-2026 ($ MILLION)
FIGURE 9 GLOBAL INTRAGASTRIC BALLOONS MARKET IN GAS-FILLED 2018-2026 ($ MILLION)
FIGURE 10 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY END USE 2018-2026 ($ MILLION)
FIGURE 11 GLOBAL INTRAGASTRIC BALLOONS MARKET IN HOSPITALS 2018-2026 ($ MILLION)
FIGURE 12 GLOBAL INTRAGASTRIC BALLOONS MARKET IN AMBULATORY SURGICAL CENTERS 2018-2026 ($ MILLION)
FIGURE 13 GLOBAL INTRAGASTRIC BALLOONS MARKET IN CLINICS 2018-2026 ($ MILLION)
FIGURE 14 GLOBAL INTRAGASTRIC BALLOONS MARKET SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 15 AMERICAS MARKET SHARE, BY COUNTRY 2016 & 2026 (%)
FIGURE 16 AMERICAS INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 17 THE UNITED STATES FOOD CONSUMPTION AS A PERCENTAGE OF CALORIES
FIGURE 18 PREVALENCE OF OBESITY IN THE US ADULTS AGED BETWEEN 20-74
FIGURE 19 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN THE US
FIGURE 20 UNITED STATES INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 21 PERCENTAGE OF OBESE POPULATION (SELF-REPORTED) IN CANADA 2015
FIGURE 22 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN CANADA
FIGURE 23 CANADA INTRAGASTRIC BALLOONS MARKET 2018-2026 ($MILLION)
FIGURE 24 BRAZIL INTRAGASTRIC BALLOONS MARKET 2018-2026 ($MILLION)
FIGURE 25 WORST OBESITY SCENARIO AMONG EMERGING COUNTRIES BY 2030
FIGURE 26 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN MEXICO
FIGURE 27 REST OF AMERICAS INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 28 EUROPEAN FOOD-BASED DIETARY GUIDELINES (FBDG)
FIGURE 29 EMEA INTRAGASTRIC BALLOONS MARKET SHARE, BY COUNTRY 2017 (%)
FIGURE 30 EMEA INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 31 GERMANY INTRAGASTRIC BALLOONS MARKET 2018-2026 ($MILLION)
FIGURE 32 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN ENGLAND
FIGURE 33 UNITED KINGDOM INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 34 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN FRANCE
FIGURE 35 FRANCE INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 36 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN ITALY
FIGURE 37 ITALY INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 38 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN SPAIN
FIGURE 39 SPAIN INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 40 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN SWITZERLAND
FIGURE 41 REST OF EUROPE INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 42 MIDDLE EAST INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 43 AFRICA INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 44 PREVALENCE OF OVERWEIGHT AND OBESITY, BY COUNTRY (2015)
FIGURE 45 APAC MARKET SHARE, BY COUNTRY 2017 (%)
FIGURE 46 APAC INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 47 JAPAN INTRAGASTRIC BALLOONS MARKET2018-2026($MILLION)
FIGURE 48 OVERWEIGHT MEN AND WOMEN AGED MORE THAN 30 YEARS IN CHINA, 2005 AND 2015
FIGURE 49 CHINA INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 50 INDIA INTRAGASTRIC BALLOONS MARKET 2018-2026 ($MILLION)
FIGURE 51 OVERWEIGHT ACT, FEMALES AND MALES, 2007-2008 AND 2011-2012 IN AUSTRALIA
FIGURE 52 OBESE ACT, FEMALES AND MALES, 2007-2008 AND 2011-2012 IN AUSTRALIA
FIGURE 53 PERCENTAGE OF OBESE POPULATION IN NEW ZEALAND
FIGURE 54 CHILDHOOD OBESITY RATES IN KOREA 2000-2020
FIGURE 55 REST OF APAC INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
COMPANIES MENTIONED
2. APOLLO ENDOSURGERY, INC.
3. ALLURION TECHNOLOGIES INC.
4. RESHAPE MEDICAL INC.
5. HÉLIOSCOPIE SA
6. SPATZ FGIA INC.
7. SILIMED, INC.
8. OBALON THERAPEUTICS INC.
9. MEDSIL
10. LIFE PARTNERS EUROPE
11. TULIP MEDICAL LTD.
12. BARONOVA, INC.
13. ENDALIS
FIGURE 1 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY GEOGRAPHY 2018-2026 ($ MILLION)
FIGURE 2 OBESITY WORLDWIDE 2016 (IN MILLIONS)
FIGURE 3 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY PRODUCT 2018-2026 ($ MILLION)
FIGURE 4 GLOBAL INTRAGASTRIC BALLOONS MARKET IN SINGLE BALLOON 2018-2026 ($ MILLION)
FIGURE 5 GLOBAL INTRAGASTRIC BALLOONS MARKET IN DUAL BALLOON 2018-2026 ($ MILLION)
FIGURE 6 GLOBAL INTRAGASTRIC BALLOONS MARKET IN TRIPLE BALLOON 2018-2026 ($ MILLION)
FIGURE 7 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY FILLING MATERIAL 2018-2026 ($ MILLION)
FIGURE 8 GLOBAL INTRAGASTRIC BALLOONS MARKET IN SALINE-FILLED 2018-2026 ($ MILLION)
FIGURE 9 GLOBAL INTRAGASTRIC BALLOONS MARKET IN GAS-FILLED 2018-2026 ($ MILLION)
FIGURE 10 GLOBAL INTRAGASTRIC BALLOONS MARKET, BY END USE 2018-2026 ($ MILLION)
FIGURE 11 GLOBAL INTRAGASTRIC BALLOONS MARKET IN HOSPITALS 2018-2026 ($ MILLION)
FIGURE 12 GLOBAL INTRAGASTRIC BALLOONS MARKET IN AMBULATORY SURGICAL CENTERS 2018-2026 ($ MILLION)
FIGURE 13 GLOBAL INTRAGASTRIC BALLOONS MARKET IN CLINICS 2018-2026 ($ MILLION)
FIGURE 14 GLOBAL INTRAGASTRIC BALLOONS MARKET SHARE, BY GEOGRAPHY, 2017 (%)
FIGURE 15 AMERICAS MARKET SHARE, BY COUNTRY 2016 & 2026 (%)
FIGURE 16 AMERICAS INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 17 THE UNITED STATES FOOD CONSUMPTION AS A PERCENTAGE OF CALORIES
FIGURE 18 PREVALENCE OF OBESITY IN THE US ADULTS AGED BETWEEN 20-74
FIGURE 19 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN THE US
FIGURE 20 UNITED STATES INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 21 PERCENTAGE OF OBESE POPULATION (SELF-REPORTED) IN CANADA 2015
FIGURE 22 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN CANADA
FIGURE 23 CANADA INTRAGASTRIC BALLOONS MARKET 2018-2026 ($MILLION)
FIGURE 24 BRAZIL INTRAGASTRIC BALLOONS MARKET 2018-2026 ($MILLION)
FIGURE 25 WORST OBESITY SCENARIO AMONG EMERGING COUNTRIES BY 2030
FIGURE 26 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN MEXICO
FIGURE 27 REST OF AMERICAS INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 28 EUROPEAN FOOD-BASED DIETARY GUIDELINES (FBDG)
FIGURE 29 EMEA INTRAGASTRIC BALLOONS MARKET SHARE, BY COUNTRY 2017 (%)
FIGURE 30 EMEA INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 31 GERMANY INTRAGASTRIC BALLOONS MARKET 2018-2026 ($MILLION)
FIGURE 32 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN ENGLAND
FIGURE 33 UNITED KINGDOM INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 34 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN FRANCE
FIGURE 35 FRANCE INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 36 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN ITALY
FIGURE 37 ITALY INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 38 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN SPAIN
FIGURE 39 SPAIN INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 40 TRENDS IN OVERWEIGHT AND OBESITY RATES, BY EDUCATION LEVEL IN SWITZERLAND
FIGURE 41 REST OF EUROPE INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 42 MIDDLE EAST INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 43 AFRICA INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 44 PREVALENCE OF OVERWEIGHT AND OBESITY, BY COUNTRY (2015)
FIGURE 45 APAC MARKET SHARE, BY COUNTRY 2017 (%)
FIGURE 46 APAC INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 47 JAPAN INTRAGASTRIC BALLOONS MARKET2018-2026($MILLION)
FIGURE 48 OVERWEIGHT MEN AND WOMEN AGED MORE THAN 30 YEARS IN CHINA, 2005 AND 2015
FIGURE 49 CHINA INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
FIGURE 50 INDIA INTRAGASTRIC BALLOONS MARKET 2018-2026 ($MILLION)
FIGURE 51 OVERWEIGHT ACT, FEMALES AND MALES, 2007-2008 AND 2011-2012 IN AUSTRALIA
FIGURE 52 OBESE ACT, FEMALES AND MALES, 2007-2008 AND 2011-2012 IN AUSTRALIA
FIGURE 53 PERCENTAGE OF OBESE POPULATION IN NEW ZEALAND
FIGURE 54 CHILDHOOD OBESITY RATES IN KOREA 2000-2020
FIGURE 55 REST OF APAC INTRAGASTRIC BALLOONS MARKET 2018-2026($MILLION)
COMPANIES MENTIONED
2. APOLLO ENDOSURGERY, INC.
3. ALLURION TECHNOLOGIES INC.
4. RESHAPE MEDICAL INC.
5. HÉLIOSCOPIE SA
6. SPATZ FGIA INC.
7. SILIMED, INC.
8. OBALON THERAPEUTICS INC.
9. MEDSIL
10. LIFE PARTNERS EUROPE
11. TULIP MEDICAL LTD.
12. BARONOVA, INC.
13. ENDALIS
